Registrational Phase 3 study for advanced melanoma immunotherapy delivered with PharmaJet's IM Needle-free System planned for ...
PharmaJet will deliver two presentations on October 27 focusing on current and future applications of their needle-free technology. The Tropis ® intradermal (ID) Needle-free Injection System overcomes ...
Single-use and reusable needle-free injection devices will be designed for precise self-administration and home use. PharmaJet injector pens are intended for needle-free subcutaneous delivery of a ...
GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, the maker of innovative, needle-free injection technology, announced that their latest research results will be presented at the World Vaccine Congress on ...
MESA, Ariz., Jan. 23, 2018 /PRNewswire/ -- Premier Distributing, dba LenisUSA.com and Lenis Medical Ltd., announced today an exclusive distribution agreement for the U.S. sales of the LENIS® ...
Amherst, N.H. - Long considered a novel technology with limited practical value, needle-free injection (NFI) is attempting to shed its image as an out-of-the-mainstream drug delivery technique. The ...
Needle-free drug delivery signals India’s next wave of biologics and biosimilar growth: Sarvesh Mutha: Nandita Vijayasimha, Bengaluru Tuesday, January 13, 2026, 08:00 Hrs [IST] ...
GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, the maker of innovative, needle-free injection technology, today announced that patient enrollment has started for the phase 1 trial in Australia using its ...
LONDON, Oct. 24, 2019 /PRNewswire/ --Roots Analysis has announced the addition of "Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) ...
Indian pharma eyes promising prospects with needle-free drug delivery transforming patient safety & comfort: Nandita Vijayasimha, Bengaluru Tuesday, January 6, 2026, 09:00 Hrs [IS ...
The global needle free injection market is anticipated to reach USD 25,057.4 million by 2023, as per a new detailed report by Market Research Future (MRFR). It is expected to exhibit a phenomenal CAGR ...
In a recent study posted to the bioRxiv* server, researchers at the United States Army Medical Research Institute of Infectious Diseases evaluated the immunogenicity of a severe acute respiratory ...